Michael Vajdy earned his graduate degree in Biotechnology from Roskilde Technical School in Denmark in 1987. He completed his Ph.D. in Medical Sciences (Medical Microbiology and Immunology) in 1995 from the University of Gothenburg in Sweden. Michael, as Postdoctoral fellow at Loyola University in Chicago (Department of Microbiology & Immunology)
joined the Laboratory of Dr. Katherine Knight to research the role of gut associated lymphoid tissue in antibody diversification in rabbits. Michael continued on to a postdoctoral fellowship and GI Cell Biology Laboratory Instructor at Harvard Medical School, Children’s Hospital, from 1996 to 1999.
Dr. Vajdy is also the Co-founder, Principal and CSO of EpitoGenesis, Inc. He invented a novel first ever all natural non-inflammatory vaccine delivery system with proven in vivo efficacy which has now been patented nationally and internationally. At EpitoGenesis, he awarded over $2.2M in non-dilutive government awards and grants within five years of company inception. He also recruited and trained scientists and interns. During a 9.5 years tenure at Chiron Corporation and Novartis Vaccines and Diagnostics, as Project Leader of a vaccine manufacturing platform technology, he created and orchestrated a team of over 25 cross-functional members to develop a novel vaccine against an emerging virus from concept to target profile design, GMP manufacturing and clinical trials with a total planned budget of $9M. He achieved five promotions within 8 years of employment at Chiron Corporation/Novartis Vaccines, and managed six direct reports. Dr. Vajdy is a recognized leader in the field of Mucosal Immunology and Vaccinology as evidenced by invitations to chair scientific sessions and panels. He is an ad hoc reviewer of NIAID study sections. He is an inventor on seven patents and author of 57, Pubmed, peer reviewed publications. He has proven expertise in design and in vitro, ex vivo and in vivo evaluation of protein, VLP, DNA and RNA based vaccines, immunopotentiating adjuvants /delivery systems and animal/human viral and bacterial immunogenicity and challenge models. He has been principal investigator or investigator on several NIH funded grants. He was formerly Visiting Associate Professor and Faculty Member, University of California, Davis. Professor in Residence, Department of Allied Health Sciences and Adjunct Full Professor, Department of Pathobiology, University of Connecticut.
In 2017 Dr. Vajdy joined the Trudeau Research Network as the Director of Vaccines and R&D Innovation.